RIPK1 activation mediates neuroinflammation and disease progression in multiple sclerosis
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Receptor interacting protein kinase 1 (RIPK1) mediates cell death and inflammatory signaling and is increased in multiple sclerosis (MS) brain samples. Here, we investigate the role of glial RIPK1 kinase activity in mediating MS pathogenesis. We demonstrate RIPK1 levels correlate with MS disease progression. We find microglia are susceptible to RIPK1-mediated cell death and identify an inflammatory gene signature that may contribute to the neuroinflammatory milieu in MS patients. We uncover a distinct role for RIPK1 in astrocytes in regulating inflammatory signaling in the absence of cell death and confirm RIPK1-kinase-dependent regulation in human glia. Using a murine MS model, we show RIPK1 inhibition attenuates disease progression and suppresses deleterious signaling in astrocytes and microglia. Our results suggest RIPK1 kinase activation in microglia and astrocytes induces a detrimental neuroinflammatory program that contributes to the neurodegenerative environment in progressive MS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971
Zhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O'Keeffe, S., Phatnani, H. P., Guarnieri, P., Caneda, C., Ruderisch, N., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.1860-14.2014 · Cited by 4,875 · cited 1×
“In the CNS, RIPK1 is expressed in all major cell types (Ofengeim et al., 2015; Zhang et al., 2014).”
Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury
Degterev, A., Huang, Z., Boyce, M., Li, Y., Jagtap, P., Mizushima, N., Cuny, G. D., Mitchison, T. J., Moskowitz, M. A., & Yuan, J. (2005) · Nature Chemical Biology · doi:10.1038/nchembio711 · Cited by 3,068 · cited 1×
“After 2 h, T/5z or T/S/Z stimulation upregulated pRIPK1, whereas the signal was abrogated by Nec-1s (N), a small-molecule RIPK1 kinase inhibitor (Figure 2A; Degterev et al., 2005, 2008).”
Self-citationZhang, Y., Sloan, S. A., Clarke, L. E., Caneda, C., Plaza, C. A., Blumenthal, P. D., Vogel, H., Steinberg, G. K., Edwards, M. S. B., Li, G., et al. (2016) · Neuron · doi:10.1016/j.neuron.2015.11.013 · Cited by 2,295
Identification of RIP1 kinase as a specific cellular target of necrostatins
Degterev, A., Hitomi, J., Germscheid, M., Ch'en, I. L., Korkina, O., Teng, X., Abbott, D., Cuny, G. D., Yuan, C., Wagner, G., et al. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.83 · Cited by 2,059
Self-citationThe Pseudokinase MLKL Mediates Necroptosis via a Molecular Switch Mechanism
Murphy, J. M., Czabotar, P. E., Hildebrand, J. M., Lucet, I. S., Zhang, J.-G., Alvarez-Diaz, S., Lewis, R., Lalaoui, N., Metcalf, D., Webb, A. I., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.06.018 · Cited by 1,220 · cited 1×
“To definitively assess the RIPK1-kinase-driven transcriptional response in the absence of cell death, we used MLKL-deficient cells (Murphy et al., 2013).”
Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases
Yuan, J., Amin, P., & Ofengeim, D. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0093-1 · Cited by 967
Self-citationMicroRNA-155 Promotes Autoimmune Inflammation by Enhancing Inflammatory T Cell Development
O'Connell, R. M., Kahn, D., Gibson, W. S. J., Round, J. L., Scholz, R. L., Chaudhuri, A. A., Kahn, M. E., Rao, D. S., & Baltimore, D. (2010) · Immunity · doi:10.1016/j.immuni.2010.09.009 · Cited by 889 · cited 2×
“…and astrocytes induced expression of various genes whose deficiency is protective in EAE or whose expression is increased in MS patients, including Bhlhe40, Mir155hg, Rgs1, and Lcn2 (Al Nimer et al., 2016; Lee and Bou Dagher, 2016; Lin et al., 2014; Murugaiyan et al., 2011; O’Connell et al., 2010).”
An updated histological classification system for multiple sclerosis lesions
Kuhlmann, T., Ludwin, S., Prat, A., Antel, J., Brück, W., & Lassmann, H. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1653-y · Cited by 692
Neurofilament phosphoforms: Surrogate markers for axonal injury, degeneration and loss
Petzold, A. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.03.015 · Cited by 688
Loss of ‘homeostatic’ microglia and patterns of their activation in active multiple sclerosis
Zrzavy, T., Hametner, S., Wimmer, I., Butovsky, O., Weiner, H. L., & Lassmann, H. (2017) · Brain · doi:10.1093/brain/awx113 · Cited by 684 · cited 1×
“This is consistent with emerging evidence suggesting MS progression partly results from an altered innate immune response within the CNS and in particular dysregulation of microglial homeostasis (Baecher-Allan et al., 2018; Ponath et al., 2018b; Voet et al., 2019; Zrzavy et al., 2017).”
Neuronal vulnerability and multilineage diversity in multiple sclerosis
Schirmer, L., Velmeshev, D., Holmqvist, S., Kaufmann, M., Werneburg, S., Jung, D., Vistnes, S., Stockley, J. H., Young, A., Steindel, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1404-z · Cited by 638
RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS
Ito, Y., Ofengeim, D., Najafov, A., Das, S., Saberi, S., Li, Y., Hitomi, J., Zhu, H., Chen, H., Mayo, L., et al. (2016) · Science · doi:10.1126/science.aaf6803 · Cited by 606 · cited 1×
“, 2017), amyotrophic lateral sclerosis (ALS) (Ito et al., 2016; Xu et al., 2018), Niemann-Pick disease type C (Cougnoux et al.”
Self-citationRIPK1 Blocks Early Postnatal Lethality Mediated by Caspase-8 and RIPK3
Dillon, C. P., Weinlich, R., Rodriguez, D. A., Cripps, J. G., Quarato, G., Gurung, P., Verbist, K. C., Brewer, T. L., Llambi, F., Gong, Y.-N., et al. (2014) · Cell · doi:10.1016/j.cell.2014.04.018 · Cited by 562 · cited 1×
“Receptor interacting protein kinase 1 (RIPK1) is a serine/threonine kinase that regulates homeostasis at cellular and tissue levels by integrating inflammatory and cell death signaling (Dillon et al., 2014; Yuan et al., 2019).”
Activation of Necroptosis in Multiple Sclerosis
Ofengeim, D., Ito, Y., Najafov, A., Zhang, Y., Shan, B., DeWitt, J. P., Ye, J., Zhang, X., Chang, A., Vakifahmetoglu-Norberg, H., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.051 · Cited by 526 · cited 16×
“Membranes were incubated overnight at 4°C with the following primary antibodies: pRIPK1 (phospho-S166; 1:1000; Cell Signaling #31122 and #65746), RIPK1 (1:1000; BD Biosciences #610459 and Cell Signaling #3493), pMLKL (phospho-S345; 1:1000; abcam #ab196436 and phospho-S358; 1:1000; Cell Signaling #91689), MLKL (1:1000;…”
InfluentialSelf-citationMicroglia in Central Nervous System Inflammation and Multiple Sclerosis Pathology
Voet, S., Prinz, M., & van Loo, G. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.11.005 · Cited by 503
TBK1 Suppresses RIPK1-Driven Apoptosis and Inflammation during Development and in Aging
Xu, D., Jin, T., Zhu, H., Chen, H., Ofengeim, D., Zou, C., Mifflin, L., Pan, L., Amin, P., Li, W., et al. (2018) · Cell · doi:10.1016/j.cell.2018.07.041 · Cited by 461 · cited 1×
“, 2017), amyotrophic lateral sclerosis (ALS) (Ito et al., 2016; Xu et al., 2018), Niemann-Pick disease type C (Cougnoux et al.”
Self-citationMicroglia turnover with aging and in an Alzheimer’s model via long-term in vivo single-cell imaging
Füger, P., Hefendehl, J. K., Veeraraghavalu, K., Wendeln, A.-C., Schlosser, C., Obermüller, U., Wegenast-Braun, B. M., Neher, J. J., Martus, P., Kohsaka, S., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4631 · Cited by 401
RIPK1 mediates a disease-associated microglial response in Alzheimer’s disease
Ofengeim, D., Mazzitelli, S., Ito, Y., DeWitt, J. P., Mifflin, L., Zou, C., Das, S., Adiconis, X., Chen, H., Zhu, H., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1714175114 · Cited by 395
Self-citationRegulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis
Geng, J., Ito, Y., Shi, L., Amin, P., Chu, J., Ouchida, A. T., Mookhtiar, A. K., Zhao, H., Xu, D., Shan, B., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00406-w · Cited by 325
Silencing MicroRNA-155 Ameliorates Experimental Autoimmune Encephalomyelitis
Murugaiyan, G., Beynon, V., Mittal, A., Joller, N., & Weiner, H. L. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003952 · Cited by 289 · cited 2×
“…and astrocytes induced expression of various genes whose deficiency is protective in EAE or whose expression is increased in MS patients, including Bhlhe40, Mir155hg, Rgs1, and Lcn2 (Al Nimer et al., 2016; Lee and Bou Dagher, 2016; Lin et al., 2014; Murugaiyan et al., 2011; O’Connell et al., 2010).”
Itoh, N., Itoh, Y., Tassoni, A., Ren, E., Kaito, M., Ohno, A., Ao, Y., Farkhondeh, V., Johnsonbaugh, H., Burda, J., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1716032115 · Cited by 253 · cited 1×
“We confirmed astrocytes downregulate cholesterol synthesis genes during EAE (Itoh et al., 2018) and demonstrated RIPK1-kinase-mediated signaling regulates ribosomal and cholesterol biosynthesis genes.”
Bittner, S., Afzali, A. M., Wiendl, H., & Meuth, S. G. (2014) · Journal of Visualized Experiments · doi:10.3791/51275 · Cited by 171 · cited 1×
“Because the C57BL/6 EAE model has a weaker, monophasic disease course (Berard et al., 2010; Bittner et al., 2014) and we observe RIPK1 upregulation, particularly in progressive MS brain samples (Figures 1A and 1B), we wanted to investigate the role of RIPK1 in a progressive model.”
Berard, J. L., Wolak, K., Fournier, S., & David, S. (2010) · Glia · doi:10.1002/glia.20935 · Cited by 147 · cited 1×
“Because the C57BL/6 EAE model has a weaker, monophasic disease course (Berard et al., 2010; Bittner et al., 2014) and we observe RIPK1 upregulation, particularly in progressive MS brain samples (Figures 1A and 1B), we wanted to investigate the role of RIPK1 in a progressive model.”
Characterization of brain lesions in a mouse model of progressive multiple sclerosis
Levy, H., Assaf, Y., & Frenkel, D. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.08.017 · Cited by 50 · cited 1×
“…the NOD-EAE model, in which mice endure initial attacks and remissions before entering a progressively worsening disease phase (Ignatius Arokia Doss et al., 2015; Levy et al., 2010). pRIPK1 and total RIPK1 were elevated in spinal cords of mice in the progressive disease phase (Figures S6A-S6C).”
Zhang, S., Su, Y., Ying, Z., Guo, D., Pan, C., Guo, J., Zou, Z., Wang, L., Zhang, Z., Jiang, Z., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1819917116 · Cited by 43
Cited by
A guide to cell death pathways
Yuan, J., & Ofengeim, D. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00689-6 · Cited by 933
Self-citationNeuroinflammation, memory, and depression: new approaches to hippocampal neurogenesis
Wu, A., & Zhang, J. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02964-x · Cited by 306
Nguyen, P. T., Makowiecki, K., Lewis, T. S., Fortune, A. J., Clutterbuck, M., Reale, L. A., Taylor, B. V., Rodger, J., Cullen, C. L., & Young, K. M. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05391-0 · Cited by 21
Neuroinflammation-on-a-chip for multiple sclerosis research: a narrative review
Berjaoui, C., Kachouh, C., Joumaa, S., Hussein Ghayyad, M., Abate Bekele, B., Ajirenike, R., Al Maaz, Z., Awde, S., Wojtara, M., Nazir, A., et al. (2024) · Annals of Medicine & Surgery · doi:10.1097/ms9.0000000000002231 · Cited by 4
Characterization of pathological stages in a mouse model of progressive multiple sclerosis
Hamano, S., Yoshimizu, T., Mori, M., Iida, A., & Yamashita, T. (2024) · Neuroscience Research · doi:10.1016/j.neures.2024.01.009 · Cited by 3
Metadata
- Authors
- Zelic, M., Pontarelli, F., Woodworth, L., Zhu, C., Mahan, A., Ren, Y., LaMorte, M., Gruber, R., Keane, A., Loring, P., Guo, L., Xia, T.-H., Zhang, B., Orning, P., Lien, E., Degterev, A., Hammond, T., & Ofengeim, D.
- Venue
- Cell Reports
- Publisher
- Elsevier BV
- Published
- 2021-05
- Volume
- 35
- Issue
- 6
- Pages
- 109112
- ISSN
- 2211-1247 (ISSN-L)
- OpenAlex
- W3163481531
- Cited by
- 133
- References
- 26
- FWCI
- 12.32
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.